|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||0.0580 - 0.0650|
|52 Week Range||0.0300 - 0.2000|
|Beta (3Y Monthly)||3.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
HOFFMAN ESTATES, IL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Wellness Center USA, Inc. (OTCQB: WCUI) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Venture between Psoria-Shield, Inc and PSI Gen 2 Funding, Inc. (“GEN2”), to further development of their next generation phototherapy device. The Joint Venture will be conducted through Neo Phototherapy, LLC (“NEO”), a recently formed Illinois limited liability company. The next generation Class II medical device is the result of 24 months of product R&D and market research based on the previous Psoria-Light (“PL 1000”) and will utilize a new custom LED emitter array, operate on a new native software platform, use current SOTA high efficient microprocessor systems, and will be smaller, lighter, quieter, and more efficient than the current PL 1000 device.
Next Generation Authentication for Anti-Counterfeiting Applications Hoffman Estates, Illinois--(Newsfile Corp. - August 8, 2018) - Wellness Center USA, Inc.'s (OTCQB: WCUI) wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, recently announced conclusion of a licensing agreement with Oak Ridge National Labs (ORNL) for next-generation authentication technology. Today, Stealth Mark is pleased to republish ORNL's June 25th press release covering news of this agreement. Stealth Mark licenses ORNL invisible micro-taggant for anticounterfeiting applicationsJune 25, 2018Media ContactShelby Whitehead, Communicationswhiteheadsm@ornl.gov, ...